ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bearish•Cross Asset Strategy
•01 Feb 2020 13:41

Korea Stock Market Monthly Recap #44 (January 2020)

The top 10 events impacting the Korean stock market, economy, & politics in January were as follows: 1) NEW CORONAVIRUS (WUHAN VIRUS) 2)...

Logo
615 Views
Share
•02 Dec 2018 21:29

The Smartkarma Week That Was in JP/KR: Nissan, J-Retail, Tesla/Panny, SK Rights, Biosimilars, Trade

This past week featured ~160 insights across the Smartkarma platform, with 35+ of them dealing with Japan, South Korea, and semiconductors/memory...

Logo
1.1k Views
Share
•04 Jun 2018 20:23

Japan & Korea @Smartkarma:  Autos, Toshiba, NTT, JDI, North Korean Détente, and Trump Trade

As these weekly summaries get written on a weekend we look at things on a Friday-to-Friday schedule but things move at a fast pace. Just a week can...

Logo
331 Views
Share
bearish•Samsung Biologics
•01 May 2018 22:55

Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas

On May 1st, 2018, Korea's Financial Supervisory Service (FSS) announced that Samsung Biologics Co., Ltd (207940 KS) violated accounting rules after...

Logo
393 Views
Share
•19 Feb 2018 10:27

Korean IPOs - Evidence-Based Analysis & The Whiplash Effect

In this report, we provide evidence-based analysis of using key criteria such as the IPO price determined at high/low end of the IPO price range...

Logo
370 Views
Share
x